ESTHER ODAGBODO: Open Payments
NPI 1831859685 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 18 payments from 8 companies in 2025. Trend: 2023 $441 · 2024 $572 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $213 |
| Lilly USA, LLC | 1 | $98 |
| Novo Nordisk Inc | 3 | $83 |
| Abbott Laboratories | 2 | $42 |
| PFIZER INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
Products named: REPATHA, ZEPBOUND, OTEZLA, Ozempic, FREESTYLE LIBRE 3, PREVNAR 20, JARDIANCE, Cologuard Collection Kit.
Industry payments across DC — which companies pay providers there.
